Terms: = Uterine cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Prognosis
23 results:
1. Endometrial cytological findings for a mesonephric-like endometrial adenocarcinoma: A case report.
Omine H; Ishida K; Sasaki N; Kato H; Nagai T; Ishikawa M; Takaoka M; Noda S; Matsuda H; Mitsuhashi A
Diagn Cytopathol; 2024 Jun; 52(6):E129-E133. PubMed ID: 38454318
[TBL] [Abstract] [Full Text] [Related]
2. Brachytherapy for targeting the immune system in cervical cancer patients.
Linares I; Berenguer Frances MÁ; Cañas R; Najjari D; Gutiérrez C; Marín S; Comas S; Guedea F; Pujol M
BMC Immunol; 2023 Aug; 24(1):23. PubMed ID: 37559025
[TBL] [Abstract] [Full Text] [Related]
3. Molecular classification of human papillomavirus-positive cervical cancers based on immune signature enrichment.
Song G; Luo J; Zou S; Lou F; Zhang T; Zhu X; Yang J; Wang X
Front Public Health; 2022; 10():979933. PubMed ID: 36203656
[TBL] [Abstract] [Full Text] [Related]
4. Re-Irradiation for Recurrent Cervical cancer: A State-of-the-Art Review.
Shen Z; Qu A; Jiang P; Jiang Y; Sun H; Wang J
Curr Oncol; 2022 Jul; 29(8):5262-5277. PubMed ID: 35892987
[TBL] [Abstract] [Full Text] [Related]
5. Salvage image-guided freehand interstitial brachytherapy for pelvic sidewall recurrence after hysterectomy for uterine malignancies.
Miyata Y; Murakami N; Okuma K; Shimizu Y; Takahashi A; Kashihara T; Kaneda T; Takahashi K; Inaba K; Sakuramachi M; Kojima K; Aoshika T; Morishima K; Nakayama Y; Itami J; Kato T; Ogo E; Igaki H
Brachytherapy; 2022; 21(5):647-657. PubMed ID: 35750619
[TBL] [Abstract] [Full Text] [Related]
6. Upregulation of PKN1 as a prognosis Biomarker for Endometrial cancer.
Govorov I; Attarha S; Kovalevska L; Andersson E; Kashuba E; Mints M
Cancer Control; 2022; 29():10732748221094797. PubMed ID: 35533253
[TBL] [Abstract] [Full Text] [Related]
7. Assessment of cervical vascularization density in patients with locally advanced squamous cell cervical carcinoma evaluated in colour Doppler and power Doppler functions.
Tomalczyk A; Tomasik B; Fijuth J; Moszynska-Zielinska M; Gottwald L
Arch Gynecol Obstet; 2022 Apr; 305(4):955-961. PubMed ID: 34586470
[TBL] [Abstract] [Full Text] [Related]
8. prognosis of the patients suffered from uterine carcinosarcoma from rural and urban areas.
Danska-Bidzinska A; Nasierowska-Guttmejer A; Bakula-Zalewska E; Bidzinski M; Wierzba W
Ginekol Pol; 2021; 92(11):774-777. PubMed ID: 33914324
[TBL] [Abstract] [Full Text] [Related]
9. Treatment Outcome and prognosis Factors of FIGO 2018 Stage III Cervical cancer Patients Treated with Definitive Concurrent Chemoradiation in Vietnam.
Phung HT; Truong MC; Nguyen LT; Dang ATV; Vu TH; Nguyen HT
Asian Pac J Cancer Prev; 2021 Mar; 22(3):853-859. PubMed ID: 33773550
[TBL] [Abstract] [Full Text] [Related]
10. gata3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma.
El-Arabey AA; Denizli M; Kanlikilicer P; Bayraktar R; Ivan C; Rashed M; Kabil N; Ozpolat B; Calin GA; Salama SA; Abd-Allah AR; Sood AK; Lopez-Berestein G
Cell Signal; 2020 Apr; 68():109539. PubMed ID: 31935430
[TBL] [Abstract] [Full Text] [Related]
11. Comparison of accuracy and long-term prognosis between computed tomography-based and magnetic resonance imaging-based brachytherapy for cervical cancer: A meta-analysis.
Wang X; Fan L; Yan W; Bao S; Liu L
J Med Imaging Radiat Oncol; 2020 Feb; 64(1):151-162. PubMed ID: 31845539
[TBL] [Abstract] [Full Text] [Related]
12. Retrospective Analysis of Intravaginal Brachytherapy in Adjuvant Treatment of Early Endometrial cancer.
Cisek P; Kieszko D; Kordzińska-Cisek I; Kutarska E; Grzybowska-Szatkowska L
Biomed Res Int; 2018; 2018():7924153. PubMed ID: 29682556
[TBL] [Abstract] [Full Text] [Related]
13. Impact of treatment time-related factors on prognoses and radiation proctitis after definitive chemoradiotherapy for cervical cancer.
Huang EY; Lin H; Wang CJ; Chanchien CC; Ou YC
Cancer Med; 2016 Sep; 5(9):2205-12. PubMed ID: 27416796
[TBL] [Abstract] [Full Text] [Related]
14. Long-term results for Stage IIIB cervical cancer patients receiving external beam radiotherapy combined with either hdr (252)Cf or hdr (60)Co intracavitary brachytherapy.
Ulinskas K; Janulionis E; Valuckas KP; Samerdokiene V; Atkocius V; Rivard MJ
Brachytherapy; 2016; 15(3):353-360. PubMed ID: 26996594
[TBL] [Abstract] [Full Text] [Related]
15. Epithelioid Angiosarcoma of the Bladder: A Series of 9 Cases.
Matoso A; Epstein JI
Am J Surg Pathol; 2015 Oct; 39(10):1377-82. PubMed ID: 25929352
[TBL] [Abstract] [Full Text] [Related]
16. Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract.
Gulmann C; Paner GP; Parakh RS; Hansel DE; Shen SS; Ro JY; Annaiah C; Lopez-Beltran A; Rao P; Arora K; Cho Y; Herrera-Hernandez L; Alsabeh R; Amin MB
Hum Pathol; 2013 Feb; 44(2):164-72. PubMed ID: 22995333
[TBL] [Abstract] [Full Text] [Related]
17. A prospective cohort study to compare treatment results between 2 fractionation schedules of high-dose-rate intracavitary brachytherapy (hdr-ICBT) in patients with cervical cancer.
Huang EY; Sun LM; Lin H; Lan JH; Chanchien CC; Huang YJ; Wang CY; Wang CJ
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):123-8. PubMed ID: 22672751
[TBL] [Abstract] [Full Text] [Related]
18. Concurrent weekly nedaplatin, external beam radiotherapy and high-dose-rate brachytherapy in patients with FIGO stage IIIb cervical cancer: a comparison with a cohort treated by radiotherapy alone.
Mabuchi S; Ugaki H; Isohashi F; Yoshioka Y; Temma K; Yada-Hashimoto N; Takeda T; Yamamoto T; Yoshino K; Nakajima R; Kuragaki C; Morishige K; Enomoto T; Inoue T; Kimura T
Gynecol Obstet Invest; 2010; 69(4):224-232. PubMed ID: 20068328
[TBL] [Abstract] [Full Text] [Related]
19. gata3 expression in estrogen receptor alpha-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival.
Engelsen IB; Stefansson IM; Akslen LA; Salvesen HB
Am J Obstet Gynecol; 2008 Nov; 199(5):543.e1-7. PubMed ID: 18599012
[TBL] [Abstract] [Full Text] [Related]
20. High dose rate intraoperative radiotherapy for recurrent cervical cancer and nodal disease.
Roth TM; Secord AA; Havrilesky LJ; Jones E; Clarke-Pearson DL
Gynecol Oncol; 2003 Oct; 91(1):258-60. PubMed ID: 14529691
[TBL] [Abstract] [Full Text] [Related]
[Next]
